Printer Friendly

ATS MEDICAL ANNOUNCES RECEIPT OF PROCEEDS

 MINNEAPOLIS, Nov. 24 ~PRNewswire~ -- Manny A. Villafana, chairman and CEO of ATS Medical, Inc. (NASDAQ-NMS: ATSI), announced that the company has received all of the proceeds from its previously announced private placement of restricted common stock and warrants. The private placement was made to international and U.S. institutions and accredited investors, with Alex. Brown & Sons Incorporated acting as exclusive placement agent. The company received a total of $9.6 million, with the potential for an additional $17 million through the exercise of warrants issued in the private placement.
 ATS Medical, Inc. manufactures and markets a new pyrolytic carbon bileaflet mechanical heart valve. The company's common stock is traded on the NASDAQ~National Market System under the symbol "ATSI."
 -0- 11~24~92
 ~CONTACT: Manuel A. Villafana, chairman~CEO; Richard Kramp, president~COO; Jack Jungbauer, treasurer~CFO; or Howard Root, general counsel, all of ATS Medical, 612-553-7736~
 (ATSI)


CO: ATS Medical, Inc. ST: Minnesota IN: MTC SU:

KH -- MN016 -- 1250 11~24~92 16:33 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 24, 1992
Words:166
Previous Article:ANGELES CORP. CLOSES TRANSACTIONS WITH INSIGNIA FINANCIAL GROUP
Next Article:INFINITE GRAPHICS OBTAINS ADDITIONAL FINANCING
Topics:


Related Articles
HELIX BIOCORE SELLS BIOCORE DIVISION AND UPDATES STATUS AND PROGRESS OF COMPANY
ATS MEDICAL ANNOUNCES FIRST CLINICAL IMPLANTS
ELAN/ATS RIGHTS OFFERING OVERSUBSCRIBED
ATS MEDICAL ANNOUNCES RECEIPT OF $510,000 IN STOCK IN SETTLEMENT OF LITIGATION WITH FORMER OFFICERS
ATS MEDICAL ANNOUNCES FINANCING AND LOWERING OF CAPITAL REQUIREMENTS
MANNY VILLAFANA ANNOUNCES 30% INCREASE IN SALES AND SUBMISSION OF IDE TO U.S. FDA
ATS MEDICAL, INC. FILES REGISTRATION STATEMENT WITH THE SEC
ATS MEDICAL, INC. ANNOUNCES SUCCESSFUL COMPLETION OF OFFERING
ATS MEDICAL RECEIVES "CE MARK" APPROVAL
MANNY VILLAFANA PRAISES HCFA DECISION TO RECOMMENCE PAYMENT FOR TESTING OF EVOLUTIONARY MEDICAL DEVICES

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters